The PharmaGuy is reporting that my buddy Ed has joined (gasp!) the blog-corps of The Wall Street Journal. I'll never bedgrugde anyone their steady paycheck -- afterall, he has a family to take care of. . .
And I know for certain that Ed will be as fiercely independent as he's ever been, regardless of the masthead under which he writes. Here's Pharma Marketing Blog's perspective on it (one I don't necessarily share, despite liking the PharmaGuy):
. . . .Will there be the same slow and subtle change in Silverman's investigative journalistic style to match the drivel that currently is published on the WSJ Health Blog? By which I mean, will we see posts like "Six Tips For Better Napping" rather than the exposés for which Ed was famous?
I hope not.
But one thing seems certain:Pharmalot is definitely dead this time. . . .
All I'll say is that nothing lasts. . . forever. Personally, I think Pharmalot's not really dead -- it's only mostly dead. In fact, it's only been mostly-dead since January 1, 2014 (that means at least nine more months until Ed sees his shadow, again!).'Nuff said.
No comments:
Post a Comment